Overview

FC Patch Low: Metabolism Study

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to investigate the effects of the transdermal patch on the parameters of hemostasis (blood clotting), lipid (fat), and carbohydrate (sugars) metabolism in healthy women who require contraception.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Treatments:
Ethinyl Estradiol
Ethinyl Estradiol-Norgestrel Combination
Ethinyl estradiol, levonorgestrel drug combination
Gestodene
Levonorgestrel